
Please try another search
Alivus Life Sciences Limited develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally. The company offers various APIs, such as olmesartan, telmisartan, solifenacin, sitagliptin, zonisamide, rosuvastatin, amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, atovaquone, etoricoxib, remogliflozin, cabozantinib, and palbociclib for various therapeutic areas, including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, immunosuppressant, respiratory and ophthalmologic agents, urology, and anti-infectives. It also provides contract development and manufacturing services to a range of multinational corporations and specialty companies. The company exports its products. Alivus Life Sciences Limited was formerly known as Glenmark Life Sciences Limited and changed its name to Alivus Life Sciences Limited in December 2024. The company was founded in 2001 and is based in Mumbai, India. Alivus Life Sciences Limited is a subsidiary of Nirma Limited.
Name | Age | Since | Title |
---|---|---|---|
Hirenbhai Karsanbhai Patel | 50 | 2024 | Non Executive Chairman |
Yasir Yusufali Rawjee | 59 | 2019 | CEO, MD & Director |
Taruvai Laxminarayanan Easwar | - | 2021 | Non-Executive Independent Director |
Kaushikbhai Nandubhai Patel | 70 | 2024 | Additional Independent Director |
Manju Agarwal | 68 | 2020 | Non-Executive Independent Director |
Savan Godiawala | - | 2024 | Additional Independent Director |
Vinod Naik | - | 2022 | Group VP, Head of Technical Operations & Whole Time Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review